What’s Behind Inconsistent Sterile Processing?
New research examines the organizational factors that make it difficult for sterile processing teams to maintain consistent practices.
New research examines the organizational factors that make it difficult for sterile processing teams to maintain consistent practices.
The FDA has added one new and three revised AAMI sterilization documents, including guidance on ethylene oxide, to its list of Recognized Consensus Standards.
AAMI, along with the Parenteral Drug Association, is calling for abstracts for the 2025 Kilmer Conference themed “Next Generation Microbiological Quality and Sterility Assurance.” The event is set for February 3-6, 2025, in Orlando, Fla. Submissions on innovations in sterilization and microbiological quality are due by August 31, 2024.
New research examines the organizational factors that make it difficult for sterile processing teams to maintain consistent practices.
ECRI is urging the Environment Protection Agency to reconsider the timing of their proposed remediation of ethylene oxide emissions from sterilization plants.
Read MoreAdvaMed represents more than 450 companies supplying the sterile medical technology upon which Americans depend.
Read MoreThe U.S. EPA is alerting residents who reside near certain commercial sterilizing plants of the health risks EtO emissions can cause.
Read MoreAir regulators are investigating several medical equipment sterilization facilities for potential health risks caused by EtO emissions.
Read MoreThe Environmental Protection Agency has announced plans to propose an air pollution rule to address emissions of ethylene oxide at commercial sterilizers.
Read MoreThe KILMER Conference prompted conversations about the need to connect the dots for sterility assurance through the product lifecycle.
Read MoreThe FDA is considering a master file pilot program for premarket approval holders whose approved devices are sterilized using radiation.